The Therapeutic Value of Monoclonal Antibodies Directed Against Immunogenic Tumor Glycoproteins

<p>Monoclonal antibodies developed against immunogenic proteins (Tumor Specific Antigens/TSA's) that are expressed in human cancers, display a unique behavioral pattern. They appear to serve in a dual role. This includes the early recognition of these immunogenic membrane proteins that ca...

Full description

Bibliographic Details
Main Author: Myron Arlen, Philip Arlen, Al Tsang, XuePing Wang, Rishab Gupta
Format: Article
Language:English
Published: Ivyspring International Publisher 2010-01-01
Series:Journal of Cancer
Online Access:http://www.jcancer.org/v01p0209.htm